Dicofarm   Report issue

For profit Phase 2
Founded: Rome Italy (1977)
Status: Left NME R&D (2001)

Organization Overview

First Clinical Trial
1991
NCT03741686
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1991

Timeline

NOW
  • Now

Alternative names

Dicofarm

Active Ingredients

Drugs in Phase 2 Trials (2)

glucomannan (2 trials)

wheat (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Heart Diseases (Phase 2)

Insulin Resistance (Phase 2)

Metabolic Syndrome (Phase 2)

Myocardial Ischemia (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2